0001209191-20-001425.txt : 20200103
0001209191-20-001425.hdr.sgml : 20200103
20200103200106
ACCESSION NUMBER: 0001209191-20-001425
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Webster Stephen W
CENTRAL INDEX KEY: 0001438421
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37355
FILM NUMBER: 20507747
MAIL ADDRESS:
STREET 1: C/O OPTIMER PHARMACEUTICALS, INC
STREET 2: 101 HUDSON STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 07302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viking Therapeutics, Inc.
CENTRAL INDEX KEY: 0001607678
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461073877
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12340 EL CAMINO REAL, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-704-4660
MAIL ADDRESS:
STREET 1: 12340 EL CAMINO REAL, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-02
0
0001607678
Viking Therapeutics, Inc.
VKTX
0001438421
Webster Stephen W
C/O VIKING THERAPEUTICS, INC.
12340 EL CAMINO REAL, SUITE 250
SAN DIEGO
CA
92130
1
0
0
0
Stock Option (Right to Buy)
7.95
2020-01-02
4
A
0
22000
0.00
A
2021-01-02
2030-01-02
Common Stock
22000
22000
D
/s/ Michael Morneau, as Attorney-in-Fact
2020-01-03